comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 00:06:52 - browse：9651

In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics. But free tuition programs are not necessarily delivering on that promise.

In this episode of the First Opinion Podcast, University of Pennsylvania oncologist and researcher Ezekiel Emanuel and Matthew Guido, a project manager in the Healthcare Transformation Institute, discuss their original research on tuition-free programs with former host Pat Skerrett, who is filling in while Torie Bosch is on maternity leave. They make the case that medical school debt is only one of many factors that influence new doctors to choose less-popular specialties and geographic locations for their residencies. Other factors including prestige, the lifetime earning potential of higher-pay specialties, which can add several millions dollars over a career, can have more sway than student debt alone. This is especially important, they say, as needs for patients with chronic illnesses are rapidly outpacing the number of primary care physicians available to give that care.

“We have undervalued both philosophically and also financially the complications of managing chronic illness,” Emanuel says. “Can we rebalance the payment system that rewards the improvements in health and therefore the attention to chronic illness through primary care?”

You can read more about Emanuel and Guido’s opinions in their essay “Free med school tuition won’t solve the shortage of primary care physicians.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： After Optum profits sink, UnitedHealth makes changes

WSS

FDA panel gives mixed vote on blood pressure devices

Why more medical students aren't specializing in primary care

Biden administration begins canceling student loan debt for 804,000 borrowers

Indictment alleges Trump's ex

In science, is the line between industry and academia shifting?

Megan Rapinoe shares emotional post following US Women's World Cup exit

Wikipedia

comprehensive

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Diversity in medical illustrations gets boost from Chidiebere Ibe

Trump demands the U.S. pay no more for drugs than other countries … again

Health AI: on the border between health care and tech

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biogen’s boardroom scandal saddles CEO with first crisis

DIEP, the 'gold standard' of breast reconstruction, is under threat

CDC advisory panel says seniors 'may' get RSV vaccine

Dobbs anniversary: the lost opportunity of abortion as health care

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

knowledge

Schizophrenia gene found to be linked to cells' energy dysfunction

Complete sequence of Y chromosome published for first time

Novo Nordisk touts Wegovy study, but still struggling with supply

After Optum profits sink, UnitedHealth makes changes

Mark Cuban is blaming the wrong people for high drug costs

Illumina slashes 2023 revenue projections yet again

hotspot

knowledge

leisure time

knowledge